Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Valencia
Clinical trial register · Spain

Clinical Trials in Valencia, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 113 Madrid 106 Seville 47 Valencia 38 L'Hospitalet de Llobregat 35
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University of Valencia61 AstraZeneca60 Novartis Pharmaceuticals42 Hoffmann-La Roche41 AbbVie39 Clear sponsor filter
Site location
Barcelona113 Madrid106 Seville47 Valencia38 L'Hospitalet de Llobregat35
All 70 locations
Target enrolment
to

Trials with a site in Valencia

38 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
Merck Sharp & Dohme LLC
Phase 3
310
Girona, Valencia, Barcelona, Madrid, Seville
2026-06-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
876
L'Hospitalet de Llobregat, Barakaldo, Barcelona, Málaga, Badajoz, Madrid, Seville, Valencia
2026-05-04
Recruiting
Merck Sharp & Dohme LLC
Phase 2
140
Santiago de Compostela, Barcelona, Madrid, Valencia
2026-04-20
Recruiting
Merck Sharp & Dohme LLC
Phase 3
758
Seville, L'Hospitalet de Llobregat, Madrid, Barcelona, Las Palmas, Valencia
2026-04-09
Recruiting
Merck Sharp & Dohme LLC
Phase 3
900
Girona, A Coruña, Madrid, Valencia, Barcelona, Córdoba
2026-02-16
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,023
Girona, Valencia, Barcelona, Córdoba, Madrid
2026-01-19
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
570
Madrid, Valencia, Barcelona, Málaga
2025-12-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
904
L'Hospitalet de Llobregat, Santander, Girona, Madrid, Valencia, Barcelona, Córdoba
2025-11-26
Recruiting
Merck Sharp & Dohme LLC
Phase 3
675
Badalona, Barcelona, A Coruña, Majadahonda, Valencia, Madrid, Seville
2025-10-08
Recruiting
Merck Sharp & Dohme LLC
Phase 3
477
Badalona, Santander, Las Palmas de Gran Canaria, Oviedo, Barcelona, Madrid, Seville, Valencia
2025-07-16
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
DrugsEpirubicin·Adriamycin·Xeloda·Sacituzumab tirumotecan
Merck Sharp & Dohme LLC
Phase 3
2,400
L'Hospitalet de Llobregat, Bilbao, Salamanca, Jaén, Santiago de Compostela, Pozuelo de Alarcón, Valencia, Barcelona
2025-06-30
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,123
L'Hospitalet de Llobregat, Girona, Barcelona, Córdoba, Madrid, Valencia
2025-05-22
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
605
L'Hospitalet de Llobregat, Majadhonda, Madrid, Valencia, Barcelona, Málaga
2025-04-15
Recruiting
Merck Sharp & Dohme LLC
Phase 3
770
Girona, Madrid, Valencia, Barcelona, Córdoba
2025-04-09
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Seville, L'Hospitalet de Llobregat, Madrid, Valencia, Barcelona
2025-03-16
Recruiting
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
NCT06395103B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, Burkitt Lymphoma, Neuroblastoma
DrugZilovertamab vedotin
Merck Sharp & Dohme LLC
Phase 1/2
90
Esplugas de Llobregat, Madrid, Valencia, Barcelona
2024-08-16
Active, closed
Merck Sharp & Dohme LLC
Phase 3
686
Barcelona, L'Hospitalet de Llobregat, Girona, Madrid, Valencia, Córdoba
2024-07-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,530
Seville, L'Hospitalet de Llobregat, A Coruña, Madrid, Majadahonda, Valencia, Barcelona
2024-06-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Pozuelo de Alarcón, Madrid, Valencia, Barcelona, Córdoba, Seville
2024-04-14
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,310
Jerez de la Frontera, Madrid, Ourense, Valencia, Lugo, Seville
2023-12-31
Recruiting
Merck Sharp & Dohme LLC
Phase 3
614
Jerez de la Frontera, A Coruña, Pozuelo de Alarcón, Málaga, Valencia, Barcelona, Madrid, Santa Cruz de Tenerife
2023-12-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
710
L'Hospitalet de Llobregat, Girona, Madrid, Valencia, Barcelona, Córdoba
2023-12-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Badalona, Terrassa, Galdakao-Usansolo, Fuenlabrada, Madrid, Torrejón de Ardoz, Valencia
2023-10-25
Recruiting
Merck Sharp & Dohme LLC
Phase 3
735
L'Hospitalet Del Llobregat, Pozuelo de Alarcón, Valencia
2023-08-08
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,089
Barcelona, Pozuelo de Alarcón, Madrid, Málaga, Valencia
2023-07-19
Recruiting
Merck Sharp & Dohme LLC
Phase 2
42
Madrid, Valencia, Barcelona
2023-01-19
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,800
Girona, Madrid, Valencia, Barcelona, Lugo, Málaga
2022-03-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
280
L'Hospitalet de Llobregat, A Coruña, Madrid, Pamplona, Valencia, Barcelona, Seville
2022-02-03
Active, closed
Merck Sharp & Dohme LLC
Phase 2
302
Santander, Barcelona, Madrid, Málaga, Pamplona, Oviedo, Valencia
2021-06-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
342
Barcelona, Pozuelo de Alarcón, Madrid, Valencia
2021-06-18
Active, closed
Merck Sharp & Dohme LLC
Phase 3
808
Badalona, Manresa, Girona, Santiago de Compostela, Las Palmas de Gran Canaria, Oviedo, Valencia, Barcelona
2021-04-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
870
Majadahonda, Pozuelo de Alarcón, Málaga, Barcelona, Seville, Valencia
2020-07-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
520
L'Hospitalet de Llobregat, Valencia, Seville
2020-05-19
Active, closed
Merck Sharp & Dohme LLC
Phase 3
755
Barcelona, Valencia, Madrid
2020-02-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
595
Badalona, Barcelona, Cáceres, Girona, Pozuelo de Alarcón, Valencia, Madrid, Seville
2019-07-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,240
L'Hospitalet de Llobregat, A Coruña, Pozuelo de Alarcón, Madrid, Valencia, Barcelona, Jaén, Seville
2018-12-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,397
Lugo, Pozuelo de Alarcón, Pamplona, Barcelona, Madrid, Valencia
2018-12-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
976
Donostia / San Sebastian, Valencia, Barcelona, Madrid, Seville
2018-09-12
Rows per page Showing 1–38 of 38
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 October 2026. https://priyalifescience.com/clinical-trials-spain/city/valencia

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 38 of those studies with a site in Valencia that also match the filters currently applied.

How many clinical trials are recruiting in Valencia?

22 of the 38 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 16 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Valencia), 38 studies
PhaseStudiesRecruitingShare
Phase 3321784.2%
Phase 2327.9%
Phase 1/2225.3%
Phase 2/3112.6%

Most active sponsors

Lead sponsors with the most studies (Valencia)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC3822
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.